Medtronic Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Los beneficios de Medtronic han disminuido a una tasa media anual de -2.6%, mientras que en la industria Medical Equipment los beneficios crecieron en un 13.5% anualmente. Los ingresos han ido creciendo a una tasa media de 1.4% al año. La rentabilidad financiera de Medtronic es de 8.1%, y sus márgenes netos son de 13%.

Información clave

-2.6%

Tasa de crecimiento de los beneficios

-2.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	8.9%
Tasa de crecimiento de los ingresos	1.4%
Rentabilidad financiera	8.1%
Margen neto	13.0%
Próxima actualización de resultados	23 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18

Medtronic: The Tide Is Turning

Aug 24

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Aug 21

Medtronic: Dark Clouds Are Clearing - Outperformance Ahead

Aug 14

Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Aug 11

Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth

Jul 15

Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Jul 09

Is Medtronic (NYSE:MDT) A Risky Investment?

Jun 21

Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter

Jun 21

Is Medtronic's Dividend In A Good Place?

Jun 14

Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Jun 03

Medtronic: Solid Q4 Earnings, Don't Fret About Guidance

May 26

Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)

May 04

Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?

Mar 10

Where Will Medtronic Stock Be In 4 Years?

Feb 17

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Medtronic. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:MDT Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
26 Jan 24	32,320	4,201	12,000	2,701
27 Oct 23	31,958	4,102	11,884	2,693
28 Jul 23	31,558	3,620	11,860	2,672
28 Apr 23	31,227	3,758	11,801	2,696
27 Jan 23	30,771	4,064	11,825	2,707
28 Oct 22	30,806	4,321	11,749	2,688
29 Jul 22	31,070	5,205	11,698	2,688
29 Apr 22	31,686	5,039	11,720	2,746
28 Jan 22	31,785	4,914	10,015	2,726
29 Oct 21	31,798	4,704	9,957	2,659
30 Jul 21	31,597	3,882	9,997	2,622
30 Apr 21	30,117	3,606	9,956	2,493
29 Jan 21	27,926	2,892	9,543	2,429
30 Oct 20	27,868	3,537	9,661	2,401
31 Jul 20	27,927	4,412	9,644	2,365
24 Apr 20	28,913	4,789	9,882	2,331
24 Jan 20	31,062	5,408	11,857	2,357
25 Oct 19	30,891	4,762	11,889	2,345
26 Jul 19	30,666	4,420	10,105	2,332
26 Apr 19	30,557	4,631	10,273	2,330
25 Jan 19	30,555	4,826	11,912	2,328
26 Oct 18	30,378	2,168	11,844	2,326
27 Jul 18	29,947	3,163	9,963	2,292
27 Apr 18	29,953	3,104	10,077	2,256
26 Jan 18	29,725	2,859	11,993	2,217
27 Oct 17	29,639	5,069	11,878	2,188
28 Jul 17	29,934	4,115	9,813	2,186
28 Apr 17	29,710	4,028	9,715	2,193
27 Jan 17	29,361	3,968	9,592	2,215
28 Oct 16	29,012	4,242	9,521	2,231
29 Jul 16	28,725	3,647	9,448	2,222
29 Apr 16	28,833	3,538	9,469	2,224
29 Jan 16	28,435	2,434	9,513	2,177
30 Oct 15	25,819	2,316	8,683	2,004
31 Jul 15	23,127	2,624	7,847	1,833
24 Apr 15	20,261	2,675	6,904	1,640
23 Jan 15	17,410	3,124	6,039	1,497
24 Oct 14	17,255	2,909	6,006	1,484
25 Jul 14	17,083	2,983	5,937	1,482
25 Apr 14	16,893	3,065	5,847	1,477
24 Jan 14	16,879	3,586	5,783	1,501
25 Oct 13	16,743	3,812	5,730	1,517
26 Jul 13	16,644	3,556	5,709	1,532

Ingresos de calidad: MDT tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(13%) de MDT son inferiores a los del año pasado (13.2%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de MDT han disminuido en un 2.6% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de MDT en el último año (3.3%) supera su media de 5 años (-2.6% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de MDT en el último año (3.3%) superó al de la industria Medical Equipment 3.3%.

Medtronic Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Medtronic plc to Report Q3, 2025 Results on Feb 18, 2025

Second quarter 2024 earnings: EPS misses analyst expectations

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: EPS misses analyst expectations

Full year 2023 earnings: EPS misses analyst expectations

Recent updates

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

Medtronic plc Receives FDA Approval for Inceptiv Closed-Loop Spinal Cord Stimulator

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

35% Undervalued? Medtronic's Future Looks Very Bright

Medtronic plc Announces New Advancements in Artificial Intelligence for Endoscopic Care by Unveiling ColonPRO

Medtronic plc Announces SMART Trial One-Year Data Demonstrates Medtronic Evolut™ Tavr Platform as Optimal Treatment for Severe Aortic Stenosis in Patients with Small Annulus, Which Is Primarily Women

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Upcoming dividend of US$0.69 per share

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Third quarter dividend of US$0.69 announced

Medtronic plc Presents New Clinical and Real-World Data on the MiniMed™ 780G System from Around the World

Medtronic plc Approves Cash Dividend for the Fourth Quarter of Fiscal Year 2024, Payable on April 12, 2024

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Insider notifies of intention to sell stock

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Medtronic plc to Report Q3, 2025 Results on Feb 18, 2025

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Medtronic plc Announces FDA Approval of Its Percept™? RC Deep Brain Stimulation System

Medtronic Diabetes Announces World's First Approval for MiniMed™ 780G System with Simplera Sync™ Disposable, all-in-one sensor

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic plc Announces FDA Approves the PulseSelect Pulsed Field Ablation System for the Treatment of Both Paroxysmal and Persistent Atrial Fibrillation

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Upcoming dividend of US$0.69 per share at 3.5% yield

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2024, Payable on January 12, 2024

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Medtronic plc Revises Earnings Guidance for the Fiscal Year 2024

Second quarter 2024 earnings: EPS misses analyst expectations

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Medtronic Faces Potential Decline Despite Financial Strength

Now 21% undervalued after recent price drop

Medtronic plc Announces Four-Year Results from the Evolut Low Risk Trial

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Orchestra BioMed Holdings, Inc Grants FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Upcoming dividend of US$0.69 per share at 3.4% yield

Medtronic Issues Statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System

Medtronic: The Tide Is Turning

Medtronic plc Raises Earnings Guidance for 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic plc Approves Cash Dividend for the Second Quarter of Fiscal Year 2024, Payable on October 13, 2023

Medtronic: Dark Clouds Are Clearing - Outperformance Ahead

Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth

Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Full year 2023 earnings: EPS misses analyst expectations

Medtronic plc Appoints Greg Lewis as New Director

Medtronic plc Presents New Data on MiniMed 780G System on Fixed Meal Dosing and Real-World Time in Range Across Wide Range of Users

Is Medtronic (NYSE:MDT) A Risky Investment?

Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter

Upcoming dividend of US$0.69 per share at 3.1% yield

Is Medtronic's Dividend In A Good Place?

Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Medtronic plc Appoints Ken Washington as Chief Technology and Innovation Officer

Medtronic plc Approves Cash Dividend for the First Quarter of Fiscal Year 2024, Payable on July 14, 2023

Medtronic: Solid Q4 Earnings, Don't Fret About Guidance

Full year 2023 earnings: EPS misses analyst expectations

Medtronic plc Announces Medtronic Extravascular ICD Global Clinical Trial Results Reinforce Device Safety and Effectiveness

Medtronic Extravascular ICD Global Clinical Trial Results Reinforce Device Safety and Effectiveness

Desglose de ingresos y gastos
Beta